Gastric mucosal inflammatory responses to H. pylori lipopolysaccharide (LPS), are characterized by the excessive NO and prostaglandin (PGE 2 ) generation due to the disturbances in nitric oxide synthase (NOS) and cyclooxygenase (COX) systems. Here, we report that the LPS-induced enhancement in gastric mucosal inducible (i) iNOS) activity and up-regulation in PGE 2 production was associated with the suppression in Akt kinase activity and the impairment in constitutive (c) cNOS activation. The stimulatory effect of the LPS on PGE 2 production, furthermore, was susceptible to suppression by COX-2 inhibitor, NS-398, and iNOS inhibitor, 1400 W. Further, we show that the countering effect of peptide hormone, ghrelin, on the LPS-induced changes was reflected in up-regulation in Akt activity and the increase in cNOS activation through phosphorylation, and accompanied by the suppression in iNOS expression and the reduction in COX-2 activity associated with the loss in COX-2 protein S-nitrosylation. Moreover, the effect of ghrelin on the LPS-induced COX-2 S-nitrosylation was subject to repression by Akt inhibition. Our findings demonstrate that induction in iNOS with H. pylori infection leads to COX-2 activation through S-nitrosylation and up-regulation in PGE 2 generation, and that ghrelin counters these untoward consequences of the LPS through Akt-mediated up-regulation in cNO-S activation required for the iNOS gene repression.
INTRODUCTION
Helicobacter pylori, a Gram-negative bacterium colonizing the gastric mucosa, is recognized as a primary cause of gastric disease, and its cell-wall lipopolysaccharide (LPS) has been identified as a potent endotoxin capable of eliciting mucosal inflammatory changes that characterize gastritis and duodenal ulcer [1] [2] [3] . Indeed, the gastric mucosal inflammatory responses to H. pylori infection in humans as well as well as those characterizing mucosal inflammatory changes in the animal model of H. pylori LPS-induced gastritis are manifested by a marked increase in epithelial cell apoptosis and proinflammatory cytokine production, and the excessive nitric oxide (NO) and prostaglandin (PGE 2 ) generation [4] [5] [6] [7] . A growing body of evidence, moreover, points to the disturbances in NO generated by nitric oxide synthase (NOS) isozyme system, and the formation of PGE 2 synthesized from arachidonic acid (AA) by the action of cyclooxygenase (COX) system, as the events defining the extent of gastric mucosal inflammatory involvement in response to H. pylori colonization [8] [9] [10] [11] [12] .
The physiological and pathophysiological implications of NO and PGE 2 depend on the type of isozyme system involved in their generation, their subcellular targeting and the local concentrations [12] [13] [14] [15] [16] . Of the three NOS isozymes responsible for NO generation, the two expressed constitutively (cNOS) are calcium/calmodulindependent and provide precise pulses of NO for a fine modulation of the cellular processes [14, 16] . The third, inducible isoform (iNOS) is calcium/calmodulin-independent, and its activation by proinflammatory cytokines and bacterial LPS provides the high output of NO that is importance to host defense against microbial invasion. However, its massive and sustained production is also associated with transcriptional disturbances and the induction of apoptosis [14] [15] [16] [17] [18] . The cyclooxygenase system consists of two COX isozymes, the constitutive isoform or COX-1, responsible for maintaining normal physiological prostaglandin production, and the inducible form or COX-2, which accounts for up-regulation in PGE 2 production in response to inflammatory stimulus [8, 9, 12] . Moreover, a large volume of data supports the existence of functional and signaling cross-talk between the products of NOS and COX systems [13, 14, [19] [20] [21] [22] .
Indeed, the stimulation of NO production through iNOS induction or the exogenous NO donors leads to COX enzymes activation and the increase in PGE 2 generation, while a decrease in PGE 2 formation has been observed in the presence of pharmacological inhibitors of NOS system [20] [21] [22] [23] . Furthermore, the COX-2 activation for the increase in PGE 2 synthesis has been linked to the enzyme protein S-nitrosylation via NO derived through LPS-elicited induction in iNOS [20] . There are also indications for the role of cNOS in the iNOS-dependent COX-2 activation [21, 24] . Interestingly, the disturbances in NO and PGE 2 production associated with H. pylori colonization are reflected in the massive upregulation in iNOS activity and the suppression of cNOS activation [4, 5, 25, 26] . Moreover, we have recently shown that Akt-mediated cNOS activation through phosphorylation at Ser 1179 plays an essential role in the modulatory influence of peptide hormone, ghrelin, on the extent of gastric mucosal inflammatory responses to H. pylori LPS [26] .
As gastric ghrelin is recognized as an important regulator of NOS and COX enzyme systems, and implicated in the control of local inflammations, gastroprotection, and modulation of the mucosal inflammatory responses to bacterial infection [18, [27] [28] [29] [30] [31] , in this study we investigated the nature of inflammatory changes induced in gastric mucosal cells by H. pylori LPS and the mechanism of ghrelin modulatory influence on the cross-talk between the NOS and COX systems. Our data revealed that the LPS-elicited induction in iNOS leads to COX-2 activation through S-nitrosylation and up-regulation in PGE 2 generation, and that ghrelin counters these untoward consequences of the LPS through up-regulation in cNOS phosphorylation and the suppression of iNOS gene induction.
MATERIALS AND METHODS

Gastric Mucosal Cell Incubation
The mucosal cells, collected by scraping the mucosa of freshly dissected rat stomachs with a blunt spatula, were suspended in five volumes of ice-cold Dulbecco's modified (Gibco) Eagle's minimal essential medium (DM-EM), supplemented with fungizone (50 µg/ml), penicillin (50 U/ml), streptomycin (50 µg/ml), and 10% fetal calf serum, and gently dispersed by trituration with a syringe, and settled by centrifugation [5] . Following rinsing, the cells were resuspended in the medium to a concentration of 2 × 10 7 cell/ml, transferred in 1 ml aliquots to DMEM in culture dishes and incubated under 95% O 2 -5% CO 2 atmosphere at 37˚C for 16 h in the presence of 0 ng/ml -200 ng/ml of H. pylori LPS [18] . In the experiments evaluating the effect of ghrelin (rat, Sigma), cNOS inhibitor, L-NAME, iNOS inhibitor, 1400 W, Akt inhibitor, SH-5 (Calbiochem), COX-1 inhibitor, SC-560, COX-2 inhibitor, NS-398 and ascorbate (Sigma), the cells were first preincubated for 30 min with the indicated dose of the agent or vehicle before the addition of the LPS. The viability of cell preparations before and during the experimentation, assessed by Trypan blue dye exclusion assay [11] , was greater than 97%.
Helicobacter pylori Lipopolysaccharide
H. pylori used for LPS preparation was cultured from clinical isolates obtained from ATCC No. 4350 [2, 5] . The bacterium was homogenized with liquid phenolchloroform-petroleum ether, centrifuged, and the LPS contained in the supernatant was precipitated with water, washed with 80% phenol solution and dried with ether. The dry residue was dissolved in a small volume of water at 45˚C, centrifuged at 100,000 × g for 4 h, and the resulting LPS sediment subjected to lyophilization.
PGE 2 and NO Quantification
The aliquots of cell suspension from the control and various experimental conditions were centrifuged at 1500 × g for 5 min and the conditioned medium supernatant collected. PGE 2 assays were carried out using an enzyme-linked immunoassay (Cayman) and 100 µl aliquots of the spent medium supernatant, according to the manufacturer's instructions. The amount of PGE 2 released into culture medium was determined by measuring the absorbance at 405 nm [30] . To assess NO production in gastric mucosal cells, we measured the stable NO metabolite, nitrite, accumulation in the culture medium using Griess reaction [32] . A 100 µl of spent culture medium was incubated for 10 min at room temperature with 0.1 ml of Griess reagent and the absorbance was measured at 570 nm.
COX-2 Activity Assay
For measurements of COX-2 activity, the gastric mucosal cells from the control and various experimental conditions were settled by centrifugation, rinsed with phosphate-buffered saline, and homogenized in 0.3 ml cold sample buffer containing 0.1 M Tris-HCl, pH 7.8, and 1 mM EDTA, centrifuged at 12,000 × g for 10 min at 4˚C, and the supernatant collected. The COX-2 activity in 40 µl aliquots of the resulting supernatant was measured using COX activity assay kit in the absence and the presence of COX-1 inhibition (SC-560), according to the manufacturer's (Cayman) instruction. The absorbance was read at 590 nm. 3 H] citrulline contained in the flow through was quantified by scintillation counting.
cNOS and iNOS Activity Assay
Akt Activity Assay
The kinase activity of Akt in gastric mucosal cells was measured with the Akt Activity Kit (Calbiochem) by quantifying phosphorylation of a biotinylated peptide substrate (GRPRTSSFAEG). The cells were lysed in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1% deoxycholate, 2 mM EDTA, 1 mM sodium orthovanadate, 1 mM PAF, and 1 mM NaF), containing protease inhibitor cocktail (Sigma), at 4˚C for 30 min, centrifuged at 14,000 × g for 15 min, and immunoprecipitated with anti-Akt antibody for 1 h at 4˚C. Protein A/G agarose beads were then added for an additional 1 h, and the immune complex was recovered by centrifugation and thoroughly washed with lysis buffer [26] . The agarose beads were then suspended for 30 min at room temperature in the kinase assay buffer, centrifuged, and the supernatants used for the Akt activity assay by following the manufacturer's instruction.
COX-2 Protein S-Nitrosylation Assay
A biotin switch procedure was employed to assess COX-2 protein S-nitrosylation [33, 34] . The gastric mucosal cells were treated with iNOS inhibitor, 1400 W (40 µM) or ghrelin (0.5 µg/ml), or Akt inhibitor, SH-5 (30 µM) + ghrelin (0.5 µg/ml), and incubated for 16 h in the presence of 100 ng/ml of H. pylori LPS. Following centrifugation at 500 × g for 5 min, the recovered cells were lysed in 0.2 ml of HEN lysis buffer (250 mM HEPES, 1 mM EDTA, 0.1 mM neocuprin, pH 7.7), and the unnitrosylated thiol groups were blocked with S-methyl methanethiosulfonate reagent at 50˚C for 20 min [34] . The proteins were precipitated with acetone, resuspended in 0.2 ml of HEN buffer containing 1% SDS, and subjected to targeted nitrothiol group reduction with sodium ascorbate (100 mM). The free thiols were then labeled with biotin and the biotinylated proteins were recovered on streptavidin beads. The formed streptavidin beadprotein complex was washed with neutralization buffer, and the bound proteins were dissociated from streptavidin beads with 50 µl of elution buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, pH 7.7) containing 1% 2-mercaptoethanol [34] . The obtained proteins were then analyzed by Western blotting.
Immunoblotting Analysis
The mucosal cells from the control and experimental treatments were collected by centrifugation and resuspended for 30 min in ice-cold lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 2 mM EDTA, 1 mM sodium orthovanadate, 4 mM sodium pyrophosphate, 1 mM PMSF, and 1 mM NaF), containing 1 µg/ml leupeptin and 1 µg/ml pepstatin [18] . Following brief sonication, the lysates were centrifuged at 12,000 g for 10 min, and the supernatants were normalized with respect to protein concentration using BCA protein assay kit (Pierce). The samples, including those subjected to biotin switch procedure, were then resuspended in loading buffer, boiled for 5 min, and subjected to SDS-PAGE using 40 µg protein/lane. The separated proteins were transferred onto nitrocellulose membranes, blocked for 1 h with 5% skim milk in Tris-buffered Tween (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween-20), and probed with specific polyclonal rabbit antibodies directed against COX-1, COX-2, and iNOS (Calbiochem). The phosphorylated cNOS (pcNOS) was analyzed using specific antibody (Calbiochem) directed against phospho-cNOS (mouse antieNOS, pSer 1179 ), and following stripping, probed with antibody against total cNOS.
Data Analysis
All experiments were carried out using duplicate sampling, and the results are expressed as means ± SD. Analysis of variance (ANOVA) and nonparametric Kruskal-Wallis tests were used to determine significance. Any difference detected was evaluated by means of post hoc Bonferroni test, and the significance level was set at P < 0.05.
RESULTS
To further ascertain the nature of gastric mucosal inflammatory responses to H. pylori and to reveal the modulatory role ghrelin, we investigated the interaction between the systems responsible for NO generation and prostaglandin production. Using rat gastric mucosal cells exposed to H. pylori key virulence factor, LPS, we demonstrated that the LPS caused a dose-dependent increase in the mucosal cell PGE 2 and NO production, which at 100 ng/ml LPS reached the respective values of 12.7-fold and 14.5-fold over that of controls (Figure 1) . Moreover, we also established that the LPS effect on NO production was reflected in a 20.5-fold up-regulation in the mucosal cell iNOS activity (0.42 cpm x 10 5 /mg protein for the control vs. 8.67 cpm × 10 5 /mg protein for 100 ng/ml LPS), and a 76.8% decrease (2.80 cpm × 10 5 /mg protein for the control vs. 0.65 cpm × 10 5 /mg protein for 100 ng/ml LPS) in the activity of cNOS (Figure 2) .
To gain additional insights into the nature of the LPS-induced changes, we examined NO production and PGE 2 generation by gastric mucosal cell in the presence of NOS and COX systems inhibition. For this, the mucosal cells prior to incubation with the LPS were pretreated with cNOS inhibitor, L-NAME and iNOS inhibitor, 1400 W (Figure 3) , or COX-1 inhibitor, SC-560 and COX-2 inhibitor, NS-398 (Figure 4) , and assayed for PGE 2 generation and NO production. As shown in Figure 3 , the effect of cNOS inhibition was reflected in a moderate up-regulation in the LPS-induced NO and PGE 2 production, while the inhibition of iNOS lead to a profound reduction in the LPS effect on the mucosal cell NO and PGE 2 production. Furthermore, the effect of the LPS on the mucosal cell capacity for NO and PGE 2 production was not discernibly affected by COX-1 inhibition (Figure 4) , whereas preincubation with COX-2 inhibitor, NS-398, produced a marked reduction in PGE 2 generation but had no effect on the LPS-induced NO generation (Figure 4) .
Further, we found that preincubation of gastric mucosal cells with ghrelin led to a concentration-dependent suppression of the LPS-induced effect on PGE 2 generation and the activity of iNOS (Figure 5) , while the activity of cNOS showed an increase (Figure 6 ). Indeed, we observed that ghrelin at 0.5 µg/ml, elicited an 84.1% drop in the LPS-induced mucosal cell PGE 2 generation and a 90.2% decrease in the activity of iNOS (Figure 5) , whereas the activity of cNOS showed a 4.4-fold increase (Figure 6) . Moreover, the increase in cNOS activation in the presence of ghrelin was associated with a concentration-dependent up-regulation in gastric mucosal cell Akt kinase activity, which at 0.5 µg/ml of ghrelin increased 2-folds over that of the LPS (Figure 6) . As cNOS is known to undergo a rapid posttranslational activation through phosphorylation at Ser 1179 [18, 29, 30] , we have also examined the effect of the LPS and ghrelin on gastric mucosal cell cNOS phosphorylation. For this, the cells prior to incubation with ghrelin were pretreated with Akt kinase inhibitor, SH-5, and the lysates were probed with antibodies directed against cNOS and phosphorylated cNOS at Ser 1179 ( Figure 7) . We observed that the LPS-induced suppression in cNOS activity was associated with the inhibition of the enzyme phosphorylation, while the up-regulation in cNOS activation by ghrelin was reflected in a marked increase in the enzyme protein phosphorylation at Ser 1179 . Moreover, the suppression of ghrelin effect on cNOS phosphoryla-tion was attained in the presence of Akt inhibitor, SH-5 (Figure 7) .
To gain further understanding of the events resulting in the suppression of H. pylori LPS-induced up-regulation in PGE 2 generation and iNOS activation by ghrelin, we examined the influence of the LPS and ghrelin on the gastric mucosal cell expression of iNOS, and COX-1 and COX-2 proteins (Figure 8) . The results revealed that the LPS-induced up-regulation in iNOS activity and PGE 2 production was associated with the induction in iNOS and COX-2 proteins expression, while the suppression of the LPS effect by ghrelin was reflected in a marked inhibition of the iNOS protein expression, but no OJGas COX-2 protein expression was discerned. We have also apparent diminution in observed that the COX-1 protein expression remained essentially unaffected by the inclusion of the LPS or ghrelin (Figure 8) . Thus, the enzymatic activity of the LPS-induced COX-2 protein for up-regulation in PGE 2 production shows an apparent dependence on NO generated by the iNOS system. Therefore, to ascertain the requirement of H. pylori LPS-induced up-regulation in COX-2 activation for NO, the mucosal cells prior to incubation with ghrelin were pretreated with iNOS inhibitor, 1400 W, or Akt inhibitor, SH-5, or nitrosothiol reducing agent, ascorbate, and assayed for COX-2 activity. We found that the LPS-induced up-regulation in COX-2 activity was subject to suppression not only by the pretreatment with ghrelin, but also showed susceptibility to iNOS inhibitor, 1400 W, whereas Akt inhibitor, SH-5, had no effect on the extent of the LPS-induced COX-2 activation (Figure 9) . Moreover, while the iNOS inhibitor, 1400 W, produced amplification in the inhibitory effect of ghrelin on COX-2 activity, the Akt inhibitor, SH-5, caused the suppression in ghrelin effectiveness. Further, we found that the LPS-induced COX-2 activation displayed susceptibility to suppression by nitrosothiol reducing agent, ascorbate, which also produced enhancement in the effect of ghrelin on COX-2 activity (Figure 9) .
Finally, we also examined the dependence of COX-2 S-nitrosylation on the LPS-induced iNOS activation by the biotin switch method [33, 34] . The gastric mucosal cells were incubated with H. pylori LPS or ghrelin + LPS in the absence and presence of Akt inhibitor, SH-5, or iNOS inhibitor, 1400 W + LPS, and the lysates following the biotin switch procedure were examined for COX-2 protein S-nitrosylation (Figure 10) . Western blot analysis revealed that COX-2 in the cells exposed to the LPS alone showed a marked increase in the protein S-nitrosylation, whereas the preincubation with iNOS inhibitor, 1400 W, resulted in the loss of the LPS-induced COX-2 S-nitrosylation. A pronounced decrease in the LPS-induced COX-2 S-nitrosylation was also attained in the presence of ghrelin. Moreover, this effect of ghrelin on COX-2 S-nitrosylation was subject to suppression by the inclusion of Akt inhibitor, SH-5. These data suggest that induction in iNOS elicited by H. pylori LPS leads to COX-2 activation through S-nitrosylation that results in an excessive PGE2 generation, and that ghrelin counters the detrimental consequences of iNOS induction by way of cNOS-dependent suppression of iNOS gene induction.
DISCUSSION
H. pylori lipopolysaccharide is recognized as a potent endotoxin capable of eliciting mucosal inflammatory Figure 9 . Effect of iNOS inhibitor, 1400 W, Akt inhibitor, SH-5, and ascorbate on the ghrelin (Gh)-induced changes in COX-2 activity in gastric mucosal cell exposed to H. pylori LPS. The cells, preincubated with 40 µM 1400 W (14 W), 30 µM SH-5 (SH), or 300 µM ascorbate (As), were treated with Gh at 0.5 µg/ml and incubated for 16h in the presence of 100 ng/ml LPS. Values represent the means ± SD of five experiments.
* P < 0.05 compared with that of control. responses akin to those that characterize gastritis and duodenal ulcer [1] [2] [3] . Indeed, H. pylori LPS, like LPS of other Gram-negative bacteria, is known to trigger a wide variety of transcriptional factors, including NF-B and AP-1, that exert transcriptional control over such important mediators of inflammation as iNOS and COX-2 systems, which along with the constitutively expressed isozyme forms, cNOS and COX-1, are responsible for NO and PGE 2 production [4] [5] [6] [20] [21] [22] . Moreover, a growing volume of data consistently points towards the existence of a functional and signaling relationship between the products of NOS and COX enzyme systems [13, 14, 19, 20] . In particular, there are strong indications for the involvement of iNOS-derived NO in COX-2 activation through S-nitrosylation for the increase in PGE 2 generation [20] [21] [22] . Furthermore, the gastric mucosal inflammatory responses to H. pylori as well as its LPS are reflected in the suppression in cNOS activation [5, 7, 25, 26] . Hence, in this study presented herein, we investigated the nature of interaction between the systems responsible for NO generation and PGE 2 production.
Using rat gastric mucosal cells exposed to H. pylori LPS, we demonstrated that the LPS-induced enhancement in iNOS activity and up-regulation in PGE 2 production was accompanied by the suppression in Akt kinase activity and the impairment in cNOS activation through phosphorylation. The stimulatory effect of the LPS on PGE 2 production was susceptible to suppression by COX-2 inhibitor, NS-398, as well as the inhibitor of iNOS, 1400 W. However, the LPS-induced up-regulation in the mucosal cell NO generation was not affected by the inhibitors of COX-1 and COX-2 systems. These latter findings are thus in keeping with the literature data as to the role of iNOS in the regulation of COX-2 activation for the increase in PGE 2 production [20] [21] [22] [23] .
Further, we found that preincubation of the mucosal cells with gastric hormone, ghrelin, recognized for its modulatory influence on the inflammatory responses to bacterial infection [18, 27, [29] [30] [31] 35] , exerted countering effect on the LPS-induced suppression in Akt activity and lead to the increase in cNOS activation through phosphorylation at Ser
1179
. We also observed that these effects of ghrelin were accompanied by the suppression in iNOS protein expression and the reduction in COX-2 activity. Moreover, ghrelin-induced up-regulation in cNOS activation was susceptible to suppression by Akt inhibitor, SH-5, which also caused the abrogation in ghrelin-induced reduction in COX-2 activity. From this, we concluded that ghrelin countering effect on H. pylori LPS-induced inflammatory changes occurs with the involvement of Akt-mediated cNOS activation through phosphorylation, and that Akt kinase plays an essential role in the action of ghrelin on COX-2 activity. Indeed, Akt kinase occupies a central role in the receptor (GHS-R)-mediated responses to ghrelin stimulation [26, 36] , and the involvement of signaling through Akt for a rapid up-regulation in cNOS activity through the enzyme protein phosphorylation at Ser 1179 is well documented [29, 30, 37] .
Our further examination of the influence of ghrelin on H. pylori LPS-induced up-regulation in iNOS activity and PGE 2 generation revealed that while the expression of COX-1 protein remained essentially unaffected by the LPS or ghrelin, the effect of the LPS was associated with the induction in iNOS and COX-2 proteins. The countering effect of ghrelin, moreover, was reflected in a marked inhibition of the iNOS protein expression, but no apparent diminution in COX-2 protein was discerned. Thus, in concordance with our earlier results, it is apparent that whilst the countering effect of ghrelin on the LPS-induced enhancement in iNOS activity is associated with the inhibition of iNOS gene expression at the transcriptional level [38] , the suppression of the LPS-induced COX-2 activity by ghrelin does not involve the inhibition in the enzyme protein expression. However, the enzymatic activity of the LPS-induced COX-2 protein for up-regulation in PGE 2 production shows an apparent dependence on NO generated by the iNOS system. Indeed, the stimulation of NO production through iNOS induction has been reported to lead to COX-2 protein modification through S-nitrosylation that results in the enzyme activation and the increase in PGE 2 generation [20] [21] [22] .
Hence, to reveal further insights into the mechanism of ghrelin suppression of the LPS-induced gastric mucosal inflammatory disturbances, we examined the COX-2 activity and its protein S-nitrosylation in the presence of the inhibitors of iNOS and Akt, as well as nitrosothiols reducing agent, ascorbate. We found that the countering effect of ghrelin on the LPS-induced up-regulation in COX-2 activity was further amplified in the presence of iNOS inhibitor, 1400 W, while the Akt inhibitor, SH-5, caused the suppression in ghrelin effectiveness. Moreover, the LPS-induced COX-2 activation displayed susceptibility to suppression by ascorbate, which also produced an amplification in ghrelin effect on the mucosal COX-2 activity. These data, together with the demonstrated susceptibility of the LPS-induced COX-2 activation to inhibition by iNOS inhibitor, 1400 W, as well as known vulnerability of S-nitrosylated proteins to reduction by ascorbate [20, 21, 26, 33, 34] , suggest that the countering effect of ghrelin on H. pylori LPS-induced changes in COX-2 activation are intimately linked to the events of Akt activation and a rapid upregulation in cNOS activity through Akt-mediated cNOS protein phosphorylation. Consequently, our results point to the involvement of cNOS in controlling the extent of iNOS-dependent COX-2 activation.
The supporting evidence as to the involvement of Akt-mediated cNOS activation in the modulatory action of ghrelin against H. pylori LPS-induced gastric mucosal consequences of iNOS induction and up-regulation in COX-2 activation comes from the results of biotin switch assay. We found that the mucosal cells exposed to incubation with H. pylori LPS showed a marked increase in COX-2 protein S-nitrosylation, while the suppression of the LPS-induced iNOS activity with a specific inhibitor, 1400 W, caused the loss in COX-2 S-nitrosylation. Further, we observed a pronounced drop in the LPSinduced COX-2 S-nitrosylation in the presence of ghrelin, the effect of which was subject to the repression by Akt inhibitor, SH-5. These findings, together with the results of COX-2 activity assays, suggest that induction in gastric mucosal iNOS expression elicited by H. pylori LPS leads to COX-2 activation through S-nitrosylation that results in an excessive PGE 2 generation. It is also apparent that ghrelin counters these untoward consequences of H. pylori via Akt-mediated up-regulation in cNOS activation that is required for the suppression of iNOS gene induction.
While the intricate details of the role of cNOS in the regulation of iNOS gene induction remain obscure, there are indications that cNOS is capable of affecting transcriptional factor NF-B activation and therefore to influence the extent of promoter activity and iNOS gene transcription [12, 21, 24] . More interestingly, the literature data suggest that S-nitrosylation of an inhibitor protein, IB kinase complex (IKK) interferes with ubiquitinylation and proteasomal degradation of IB, thus preventing the nuclear translocation of NF-B, and resulting in its inability to promote target gene transcription [39] [40] [41] . Furthermore, we have shown that the LPS-induced suppression in cNOS activity was associated with the induction in iNOS protein expression, while the countering effect of ghrelin, like that NF-B inhibitor, PPM-18, was reflected in a marked inhibition of the iNOS protein expression [38] . Moreover, the effect of ghrelin was intimately linked to Akt-mediated cNOS activation through phosphorylation [26] .
Taken together, these observations lead us to postulate that the initial phase gastric mucosal inflammatory responses elicited by H. pylori involves the suppression in Akt kinase-dependent cNOS activation that leads to abrogation of cNOS-mediated IKK S-nitrosylation and the increase in proteasomal degradation of IB, thus allowing NF-B translocation to the nucleus to promote iNOS gene transcription. The induction in iNOS expression, in turn, leads to iNOS-mediated COX-2 activation through S-nitrosylation that results in an excessive PGE 2 generation. We also postulate that ghrelin counters these untoward consequences of H. pylori LPS via up-regulation in Akt-dependent cNOS activation through phosphorylation that results in up-regulation in cNOS-mediated IKK coplex S-nitrosylation which interferes with proteasomal degradation of IB, thereby preventing the nuclear translocation of NF-B and the induction in iNOS gene transcription. Hence, the repression of iNOS expression by ghrelin triggers the loss in COX-2 activation through iNOS-dependent S-nitrosylation and leads to a reduction in PGE 2 generation.
